Kimia Biosciences Limited (KIMIABL) Share Price
BSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE285U01025
Key metrics
- Market Cap
- ₹132 Cr
- P/E Ratio
- —
- EPS
- —
- Book Value
- —
- P/B Ratio
- —
- ROE
- —
- ROCE
- —
- Debt / Equity
- —
- Net Margin
- —
- Revenue Growth
- —
- Profit Growth
- —
- Dividend Yield
- —
- 52W High
- ₹43.28
- 52W Low
- ₹23.20
- Market Cap Band
- micro cap
- Face Value
- —
About Kimia Biosciences Limited
Kimia Biosciences Limited manufactures and sells active pharmaceutical ingredients (APIs) in India. The company offers and develops APIs in the categories, including gastrointestinal agent, anti-coagulant, anti-hypertensive, lipid lowering agents, vitamin, anti-histamine, anti-convulsant, central stimulant, anti-diabetic, and anti-bacterial, as well as anti-psychotic, anti-fungal, urologicals, anti-inflammatory, prokinetic agent, cholelithiasis agent, anti-asthmatic, anti-depressant, anti-acne, decongestant, and anti-virals. It exports its products. Kimia Biosciences Limited was formerly known as Laurel Organics Ltd and changed its name to Kimia Biosciences Limited January 2019. The company was incorporated in 1993 and is based in New Delhi, India.
- Headquarters
- New Delhi, India
- Promoter Holding
- 90.96%
The full Kimia Biosciences Limited analysis
Create a free account to open the complete KIMIABL deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.